Comprehensive Stock Comparison
Compare Omega Healthcare Investors, Inc. (OHI) vs Welltower Inc. (WELL) vs Ventas, Inc. (VTR) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | WELL | 38.0% revenue growth vs OHI's 10.7% |
| Value | OHI | Lower P/E (24.3x vs 114.3x) |
| Quality / Margins | OHI | 50.2% net margin vs VTR's 4.3% |
| Stability / Safety | OHI | Beta 0.10 vs WELL's 0.29 |
| Dividends | OHI | 5.3% yield; WELL, VTR pay no meaningful dividend |
| Momentum (1Y) | OHI | +38.3% vs VTR's +27.3% |
| Efficiency (ROA) | OHI | 6.2% ROA vs VTR's 0.9%, ROIC 5.7% vs 2.5% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Omega Healthcare Investors is a real estate investment trust that owns and leases skilled nursing and assisted living facilities to healthcare operators. It generates revenue primarily through triple-net leases — where tenants pay rent plus property expenses — with skilled nursing facilities representing the majority of its portfolio. The company's moat lies in its specialized healthcare real estate expertise and diversified portfolio of essential healthcare properties across the US and UK.
Welltower is a healthcare-focused real estate investment trust that owns and invests in seniors housing communities, post-acute care facilities, and outpatient medical properties. It generates revenue primarily through rental income from its healthcare real estate portfolio — with seniors housing contributing roughly 60% of net operating income, outpatient medical properties about 25%, and post-acute care facilities the remainder. The company's competitive advantage lies in its scale and strategic partnerships with leading healthcare operators, creating a diversified portfolio concentrated in high-growth markets across the U.S., Canada, and the U.K.
Ventas is a healthcare-focused real estate investment trust that owns and operates senior housing communities, medical office buildings, and life science research facilities. It generates revenue primarily through rental income from its diversified portfolio — roughly 60% from senior housing, 25% from medical office buildings, and 15% from life science and hospital properties. The company's competitive advantage lies in its scale, diversified healthcare property portfolio, and long-term relationships with leading healthcare operators across multiple care settings.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 3 stocks. BestLagging
Financial Scorecard
OHI leads in 4 of 6 categories (Financial Metrics, Valuation Metrics). WELL leads in 2 (Total Returns, Analyst Outlook).
Financial Metrics (TTM)
WELL is the larger business by revenue, generating $10.8B annually — 9.1x OHI's $1.2B. OHI is the more profitable business, keeping 50.2% of every revenue dollar as net income compared to VTR's 4.3%. On growth, WELL holds the edge at +46.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | OHIOmega Healthcare … | WELLWelltower Inc. | VTRVentas, Inc. |
|---|---|---|---|
| RevenueTrailing 12 months | $1.2B | $10.8B | $5.6B |
| EBITDAEarnings before interest/tax | $1.0B | $2.6B | $2.2B |
| Net IncomeAfter-tax profit | $597M | $934M | $238M |
| Free Cash FlowCash after capex | $629M | $2.1B | $1.2B |
| Gross MarginGross profit ÷ Revenue | +72.3% | +20.9% | +42.0% |
| Operating MarginEBIT ÷ Revenue | +60.2% | +4.9% | +14.7% |
| Net MarginNet income ÷ Revenue | +50.2% | +8.6% | +4.3% |
| FCF MarginFCF ÷ Revenue | +52.9% | +19.4% | +20.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.3% | +46.3% | +20.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +34.1% | -26.3% | +2.1% |
Valuation Metrics
At 31.1x trailing earnings, OHI trades at a 80% valuation discount to VTR's 159.6x P/E. On an enterprise value basis, OHI's 18.5x EV/EBITDA is more attractive than WELL's 54.4x.
| Metric | OHIOmega Healthcare … | WELLWelltower Inc. | VTRVentas, Inc. |
|---|---|---|---|
| Market CapShares × price | $13.5B | $144.3B | $40.4B |
| Enterprise ValueMkt cap + debt − cash | $17.8B | $142.0B | $53.1B |
| Trailing P/EPrice ÷ TTM EPS | 31.14x | 149.01x | 159.56x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.31x | 73.28x | 114.29x |
| PEG RatioP/E ÷ EPS growth rate | 187.73x | — | — |
| EV / EBITDAEnterprise value multiple | 18.45x | 54.40x | 24.07x |
| Price / SalesMarket cap ÷ Revenue | 12.81x | 13.31x | 6.93x |
| Price / BookPrice ÷ Book value/share | 2.76x | 3.26x | 3.08x |
| Price / FCFMarket cap ÷ FCF | 17.98x | 50.06x | 31.53x |
Profitability & Efficiency
OHI delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $2 for VTR. WELL carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.04x. On the Piotroski fundamental quality scale (0–9), OHI scores 8/9 vs WELL's 5/9, reflecting strong financial health.
| Metric | OHIOmega Healthcare … | WELLWelltower Inc. | VTRVentas, Inc. |
|---|---|---|---|
| ROE (TTM)Return on equity | +11.0% | +2.2% | +1.9% |
| ROA (TTM)Return on assets | +6.2% | +1.4% | +0.9% |
| ROICReturn on invested capital | +5.7% | +0.9% | +2.5% |
| ROCEReturn on capital employed | +7.2% | +0.9% | +3.2% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 7 |
| Debt / EquityFinancial leverage | 1.02x | 0.07x | 1.04x |
| Net DebtTotal debt minus cash | $4.3B | -$2.2B | $12.6B |
| Cash & Equiv.Liquid assets | $518M | $5.0B | $786M |
| Total DebtShort + long-term debt | $4.8B | $2.8B | $13.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.98x | 0.81x | 1.35x |
Total Returns (with DRIP)
A $10,000 investment in WELL five years ago would be worth $32,119 today (with dividends reinvested), compared to $16,302 for OHI. Over the past 12 months, OHI leads with a +38.3% total return vs VTR's +27.3%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.6% vs VTR's 23.5% — a key indicator of consistent wealth creation.
| Metric | OHIOmega Healthcare … | WELLWelltower Inc. | VTRVentas, Inc. |
|---|---|---|---|
| YTD ReturnYear-to-date | +9.9% | +11.2% | +11.4% |
| 1-Year ReturnPast 12 months | +38.3% | +36.8% | +27.3% |
| 3-Year ReturnCumulative with dividends | +110.2% | +190.2% | +88.4% |
| 5-Year ReturnCumulative with dividends | +63.0% | +221.2% | +80.6% |
| 10-Year ReturnCumulative with dividends | +132.8% | +270.5% | +97.3% |
| CAGR (3Y)Annualised 3-year return | +28.1% | +42.6% | +23.5% |
Risk & Volatility
OHI is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than WELL's 0.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | OHIOmega Healthcare … | WELLWelltower Inc. | VTRVentas, Inc. |
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.10x | 0.29x | 0.23x |
| 52-Week HighHighest price in past year | $49.14 | $215.56 | $87.87 |
| 52-Week LowLowest price in past year | $35.04 | $130.29 | $60.15 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +96.1% | +98.1% |
| RSI (14)Momentum oscillator 0–100 | 68.6 | 69.0 | 77.7 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 2.5M | 2.3M |
Analyst Outlook
Analyst consensus: OHI as "Hold", WELL as "Buy", VTR as "Buy". Consensus price targets imply 6.9% upside for WELL (target: $221) vs 1.8% for OHI (target: $49). OHI is the only dividend payer here at 5.25% yield — a key consideration for income-focused portfolios.
| Metric | OHIOmega Healthcare … | WELLWelltower Inc. | VTRVentas, Inc. |
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $49.14 | $221.45 | $88.70 |
| # AnalystsCovering analysts | 28 | 34 | 32 |
| Dividend YieldAnnual dividend ÷ price | +5.3% | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 0 |
| Dividend / ShareAnnual DPS | $2.53 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| Omega Healthcare In… (OHI) | 100 | 109.22 | +9.2% |
| Welltower Inc. (WELL) | 100 | 249.04 | +149.0% |
| Ventas, Inc. (VTR) | 100 | 147.84 | +47.8% |
Welltower Inc. (WELL) returned +221% over 5 years vs Omega Healthcare In… (OHI)'s +63%. A $10,000 investment in WELL 5 years ago would be worth $32,119 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Omega Healthcare In… (OHI) | $901M | $1.1B | +16.7% |
| Welltower Inc. (WELL) | $4.3B | $10.8B | +154.9% |
| Ventas, Inc. (VTR) | $3.4B | $5.8B | +69.4% |
Welltower Inc.'s revenue grew from $4.3B (2016) to $10.8B (2025) — a 11.0% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Omega Healthcare In… (OHI) | 40.7% | 38.6% | -5.0% |
| Welltower Inc. (WELL) | 25.4% | 8.6% | -65.9% |
| Ventas, Inc. (VTR) | 18.9% | 4.3% | -77.1% |
Welltower Inc.'s net margin went from 25% (2016) to 9% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Omega Healthcare In… (OHI) | 54 | 24.4 | -54.8% |
| Welltower Inc. (WELL) | 50.6 | 133.5 | +163.8% |
| Ventas, Inc. (VTR) | 15.9 | 143.3 | +801.3% |
Omega Healthcare Investors, Inc. has traded in a 16x–54x P/E range over 8 years; current trailing P/E is ~31x. Welltower Inc. has traded in a 27x–219x P/E range over 9 years; current trailing P/E is ~149x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Omega Healthcare In… (OHI) | 1.9 | 1.55 | -18.4% |
| Welltower Inc. (WELL) | 2.81 | 1.39 | -50.5% |
| Ventas, Inc. (VTR) | 1.86 | 0.54 | -71.0% |
Welltower Inc.'s EPS grew from $2.81 (2016) to $1.39 (2025) — a -8% CAGR.
Chart 6Free Cash Flow — 5 Years
Omega Healthcare Investors, Inc. generated $749M FCF in 2024 (+20% vs 2021). Welltower Inc. generated $3B FCF in 2025 (+129% vs 2021).
OHI vs WELL vs VTR: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is OHI or WELL or VTR a better buy right now?
Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 31.1x trailing P/E (24.3x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OHI or WELL or VTR?
On trailing P/E, Omega Healthcare Investors, Inc. (OHI) is the cheapest at 31.1x versus Ventas, Inc. at 159.6x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 24.3x.
03Which is the better long-term investment — OHI or WELL or VTR?
Over the past 5 years, Welltower Inc. (WELL) delivered a total return of +221.2%, compared to +63.0% for Omega Healthcare Investors, Inc. (OHI). A $10,000 investment in WELL five years ago would be worth approximately $32K today (assuming dividends reinvested). Over 10 years, the gap is even starker: WELL returned +270.5% versus VTR's +97.3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OHI or WELL or VTR?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc. (OHI) is the lower-risk stock at 0.10β versus Welltower Inc.'s 0.29β — meaning WELL is approximately 196% more volatile than OHI relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 7% versus 104% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — OHI or WELL or VTR?
Omega Healthcare Investors, Inc. (OHI) is the more profitable company, earning 38.6% net margin versus 4.3% for Ventas, Inc. — meaning it keeps 38.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62.7% versus 4.9% for WELL. At the gross margin level — before operating expenses — OHI leads at 98.6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is OHI or WELL or VTR more undervalued right now?
On forward earnings alone, Omega Healthcare Investors, Inc. (OHI) trades at 24.3x forward P/E versus 114.3x for Ventas, Inc. — 90.0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 6.9% to $221.45.
07Which pays a better dividend — OHI or WELL or VTR?
In this comparison, OHI (5.3% yield) pays a dividend. WELL, VTR do not pay a meaningful dividend and should not be held primarily for income.
08Is OHI or WELL or VTR better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc. (OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.10), 5.3% yield, +132.8% 10Y return). Both have compounded well over 10 years (OHI: +132.8%, VTR: +97.3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between OHI and WELL and VTR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: OHI is a mid-cap income-oriented stock; WELL is a mid-cap quality compounder stock; VTR is a mid-cap quality compounder stock. OHI pays a dividend while WELL, VTR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.